Literature DB >> 25516530

Hide and seek: does the toe-brachial index allow for earlier recognition of peripheral arterial disease in diabetic patients?

R M Stoekenbroek1, D T Ubbink2, J A Reekers3, M J W Koelemay2.   

Abstract

OBJECTIVE/
BACKGROUND: Arterial calcification may render the ankle-brachial index (ABI) unreliable in diabetic patients. Although guidelines recommend the toe-brachial index (TBI) for patients with falsely elevated ABI arbitrarily defined as an ABI > 1.4, arterial calcification is also common among diabetic patients with an ABI ≤ 1.4. This could result in a "falsely normalized" ABI and under-diagnosis of peripheral arterial disease (PAD). We investigated whether diabetes invalidates the ABI as opposed to the TBI, and if the TBI may therefore be more suitable for detecting PAD in diabetic patients.
METHODS: The difference between ABI and TBI was compared between diabetic and non-diabetic patients with an ABI ≤ 1.4 referred to the vascular laboratory. A Bland-Altman plot was constructed to assess whether ABI-TBI differences were dependent on the magnitude of the measurements. Subgroup analyses were performed for patients with a normal ABI, and for patients with critical ischemia.
RESULTS: The population comprised 161 diabetic (252 limbs) and 160 non-diabetic (253 limbs) patients (mean age 67). Median ABIs (0.79 vs. 0.80) were similar, while median TBI was 0.07 higher in diabetics (p = 0.024). The ABI-TBI difference in diabetics and non-diabetics was similar (0.32 vs. 0.35; p = .084), and was also similar for patients with a normal ABI. Moreover, ABI-TBI differences in diabetic- and non-diabetic patients overlapped, irrespective of the magnitude of the measurements. Diabetes was not associated with larger differences between ankle and toe pressures (mean difference -0.9 mmHg, 95% confidence interval -15 to 13 mmHg) among patients with critical ischemia.
CONCLUSION: No evidence was found that the TBI may overcome the potentially invalidated ABI in diabetic patients with an ABI ≤ 1.4. ABI and TBI are strongly associated, and this relationship is not influenced by diabetes. Therefore, the TBI does not allow for earlier detection of ischemia in diabetes.
Copyright © 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ankle-brachial index (ABI); Arterial insufficiency; Diabetes; Media sclerosis; Peripheral arterial disease (PAD); Toe-brachial index (TBI)

Mesh:

Year:  2014        PMID: 25516530     DOI: 10.1016/j.ejvs.2014.10.020

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  5 in total

1.  Toe-Brachial Index in the Second Toe: Substitutability to Toe-Brachial Index in the Great Toe and Ankle-Brachial Index.

Authors:  Yoshiko Watanabe; Hisao Masaki; Kenji Kojima; Kazuo Tanemoto
Journal:  Ann Vasc Dis       Date:  2016-11-22

2.  Percutaneous Transluminal Angioplasty and Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia (PADI) Trial.

Authors:  Marlon I Spreen; Jasper M Martens; Bettina E Hansen; Bob Knippenberg; Elke Verhey; Lukas C van Dijk; Jean-Paul P M de Vries; Jan-Albert Vos; Gert Jan de Borst; Evert-Jan P A Vonken; Jan J Wever; Randolph G Statius van Eps; Willem P Th M Mali; Hans van Overhagen
Journal:  Circ Cardiovasc Interv       Date:  2016-02       Impact factor: 6.546

3.  The Role of Interventional Radiology in the Treatment of Arterial Diabetic Foot Disease.

Authors:  Jim A Reekers
Journal:  Cardiovasc Intervent Radiol       Date:  2016-07-19       Impact factor: 2.740

4.  Toe pressure and toe brachial index are predictive of cardiovascular mortality regardless of the most diseased arterial segment in symptomatic lower-extremity artery disease-A retrospective cohort study.

Authors:  V Koivunen; M Juonala; M Venermo; M Laivuori; J M Jalkanen; H H Hakovirta
Journal:  PLoS One       Date:  2021-11-15       Impact factor: 3.240

5.  Association of Ankle-Brachial and Toe-Brachial Indexes With Mortality in Patients With CKD.

Authors:  Thejas P Kamath; Ritika Prasad; Matthew A Allison; Michael C Criqui; Joachim H Ix; Dena E Rifkin; Pranav S Garimella
Journal:  Kidney Med       Date:  2020-01-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.